http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1323414-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3fe0901dd5ca3ec61527f7d59664274
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5015
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23P10-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23P10-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
filingDate 2002-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ffc8a48feb4f28f134f079e0294d62c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23807c1b13d2708ea1f0e0881c3b734c
publicationDate 2003-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1323414-A2
titleOfInvention Improvements on products intended for human or animal consumption
abstract The improvements which are the subject of the invention envisage that the products in question may be in the form of granules or particles consisting of active materials alone, or associated with others, or in combination with excipients, and a hydrophobic agent substantially insoluble in water, in solid state, with a melting point between 10 and 80 degrees centigrade, keeping the active ingredient isolated and preventing it from starting its activity until the fusion has taken place hydrophobic agent.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005084446-A1
priorityDate 2001-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1108365-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0443572-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5731006-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5807594-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5976598-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5008118-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6251478-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5593690-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5545410-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID103023
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71188
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127700386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10953859
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394131
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394130
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517430

Total number of triples: 39.